Bluejay Diagnostics announces CTO departure

Published 28/05/2025, 22:30
Bluejay Diagnostics announces CTO departure

Bluejay Diagnostics , Inc. (NASDAQ:BJDX), a medical devices company with a market capitalization of $2.5 million, has confirmed the departure of its Chief Technology Officer, Jason Cook. According to InvestingPro data, the company maintains a healthy liquidity position with more cash than debt on its balance sheet. The separation agreement, which will be effective as of June 4, 2025, was mutually entered into on May 28, 2025, and will see Dr. Cook’s employment officially cease on May 30, 2025.

The agreement follows the discussions previously disclosed in the company’s quarterly report for the period ending March 31, 2025. According to the terms, Dr. Cook will receive severance payments as per his existing employment contract. These payments include a six-month base salary and a pro-rated target bonus for the 2025 calendar year. These severance payments are contingent upon Dr. Cook’s adherence to ongoing confidentiality and cooperation covenants.

Additionally, the agreement allows for the possibility of Dr. Cook serving as a paid consultant post-employment, subject to future agreement on terms by both parties.

This development was detailed in an 8-K filing with the Securities and Exchange Commission, which includes the full text of the Separation Agreement as Exhibit 10.1. The information in this article is based on statements from the press release and the SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.